Trastuzumab Rezetecan in Human Epidermal Growth Factor Receptor 2-Expressing Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma and Colorectal Cancer: A Multicenter, Open-Label, Phase I Trial.

Journal:

Journal of Clinical Oncology

Published:

2026-03-05

DOI:

10.1200/jco-25-00716

Affiliations:

22

Authors:

25

Go to article

Institutions	Authors	Share
Hengrui, China	4.000000	0.16
Xiangya Hospital, CSU, China	2.000000	0.08
Tongji Hospital (TJH), HUST, China	2.000000	0.08
The Affiliated Hospital of Qingdao University, China	2.000000	0.08
The First Affiliated Hospital of Bengbu Medical University, China	2.000000	0.08
The First Affiliated Hospital, SYSU, China	2.000000	0.08
Tianjin Medical University Cancer Institute and Hospital, TMU, China	1.000000	0.04
Zhongshan Hospital, Fudan University, China	1.000000	0.04
Jiangsu Cancer Hospital, China	1.000000	0.04
Shanghai East Hospital, Tongji University, China	1.000000	0.04
Hunan Cancer Hospital, China	1.000000	0.04
Shanxi Cancer Hospital, China	1.000000	0.04
Peking University International Hospital (PKUIH), China	1.000000	0.04
The First Affiliated Hospital of Nanchang University, China	1.000000	0.04
The Sixth Affiliated Hospital, SYSU, China	1.000000	0.04
Harbin Medical University Cancer Hospital, China	1.000000	0.04
Henan Cancer Hospital, ZZU, China	1.000000	0.04

Interested in Oncology and Carcinogenesis?